期刊文献+

食管鳞状细胞癌中SDF-1的表达及DC抗肿瘤活性的影响

SDF-1 EXPRESSION AND AFFECTION TO THE ACTIVITY OF DC ANTI-TUMOR IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
下载PDF
导出
摘要 目的探讨食管鳞癌中基质细胞衍生因子-1的表达与树突状细胞密度的相互关系及它们与患者临床病理特征的关系。方法运用免疫组化和原位杂交方法检测49例食管鳞癌组织中基质细胞衍生因子-1蛋白和mRNA、S-100蛋白标记的树突状细胞的表达,根据染色面积和染色强弱判断它们表达的水平。结果(1)肿瘤细胞分化和浸润深度与基质细胞衍生因子-1的表达呈正相关(rs分别为0.498、0.313,P<0.05);而与S-100蛋白阳性树突状细胞的密度呈负相关(rs分别为-0.501、-0.466,P<0.05)。(2)基质细胞衍生因子-1与树突状细胞密度间存在负相关性(rs=-0.619,P<0.05)。结论(1)基质细胞衍生因子-1蛋白的表达与食管鳞癌的临床病理特征存在明显相关性。(2)食管鳞癌中基质细胞衍生因子-1的表达可影响鳞癌组织中树突状细胞的密度,可能影响宿主的抗肿瘤能力及肿瘤的浸润转移。 Objective To investigate the relationship between expression of SDF - 1 and density of Dendritic cell (DC) in esophageal squamous cell carcinoma and their association with patients' clinicopathological features. Methods The expression of SDF - 1 and DC in 49 specimens of esophageal squamous cell carcinoma was detected by immunohistochemical technique and in situ hybridization, using anti - SDF - 1 monoclonal antibody, anti - S - 100 monoclonal antibody and labeled SDF - 1 mRNA probes. The results were evaluated according to the staining area and intensity . Results ( 1 ) SDF - 1 expression was actively associated with tumor grade , depth ( rs, respectively 0. 498,0. 313, P 〈 0.05 ) ; There was a close negative relation between the density of S - 100 positive DC and tumor grade , depth (rs, respectively - 0. 501, - 0. 466, P 〈 0. 05 ). (2) There was a reverse correlation between the expression of SDF- 1 and the density of DC (rs = -0. 619 ,P 〈0.05 ). Conclusion (1)SDF- 1 protein is associated with clinicopathological features of esophageal squamous cell carcinoma . (2) Expression of SDF - 1 might affect the density of DC and can affect the immune system and the invasion and metastasis of esophageal squamouscell carcinoma.
作者 乔辉 耿排力
机构地区 青海大学医学院
出处 《青海医学院学报》 CAS 2009年第2期77-81,共5页 Journal of Qinghai Medical College
关键词 食管肿瘤 基质细胞衍生因子 树突状细胞 Esophageal squamous cell carcinoma Stromal cell - derived factor - 1 Dendritic cell
  • 相关文献

参考文献14

  • 1Arai A , Jin A , Yan W, et al . SDF-1 synergistically enhances IL-3-induced activation of the Raf-1/MEK/Erk signaling pathway through activation of Rac and its effector Pak kinases to promote hematopoiesis and chemotaxis[J]. Cell Signal,2005, 17(4): 497 - 506.
  • 2Kuhlmann CR , Schaefer CA , Reinhold L , et al . Signalling mechanisms of SDF-induced endothelial cell proliferation and migration[J]. Biochem Biophys Res Commun , 2005 ,335(4):1107 - 1114.
  • 3Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4[J]. Semin Cancer Biol, 2004, 4(3): 171-179.
  • 4Taichman R ,Coopet C ,Keller E , et al . Use of the stromal cell-derived Factor-1/CXCR4 pathway in prostate cancer metastasis to Bone[J]. Cancer Res ,2002,62(6):1832-1837.
  • 5Kavanaugh DY, Carbone DP. Immunologic dysfunction in cancer[J]. Hematal-Oncol Clin North America, 1996, 10: 927 - 931.
  • 6Zou W, Machelon V, Coulomb - L ’Hermin A, et al. Stromal - derived factor - 1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells[J]. NatMed, 2001, 7(12): 1339-1346.
  • 7张晓智,安怀伦,张学斌.食管癌及其区域淋巴结中S-100^+树突状细胞的免疫组化研究[J].西安医科大学学报,1998,19(2):215-218. 被引量:7
  • 8Muller A ,Homey B ,Soto H , et al . Involvement of chemokine receptors in breast cancer metastasis[J]. Nature ,2001 ,410 (6824) :50-56.
  • 9Tsujitani S, Kakeji Y, Watanabe A, et al. Infiltration of dendritic cells in relation to tumor invasion and dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer[J]. Cancer, 1990, 66: 2012 -2016.
  • 10金姝,葛海良.树突状细胞在免疫耐受中的作用[J].现代免疫学,2004,24(2):175-176. 被引量:9

二级参考文献39

  • 1龚西騟,孟刚.大肠癌区域性淋巴结中S-100^+细胞的研究[J].皖南医学院学报,1993,12(2):86-88. 被引量:2
  • 2曹雪涛.树突状细胞的基础与临床研究进展[J].中国免疫学杂志,1998,14(3):161-161.
  • 3[1]Tsujitani S,Kakeji Y,Watanabe A,et al.Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer[J].Cancer,1990,66(9):2012-2016.
  • 4[2]Lespagnard L,Gancberg D,Rouas G,et al.Tumor-infiltrating dendritic cells in adenocarcinomas of the breast:a study of 143 neoplasms with correlation to usual prognostic and to clinical outcome[J].Int J Cancer,1999,84(3):309-314.
  • 5[3]Gabrilovich DI,Corak J,Ciernik IF,et al.Decreased antigen presentation by dendritic cells in patients with breast cancer[J].Clin Cancer Res,1997,3(3):483-490.
  • 6[4]Almand B,Resser JR,Lindman B,et al.Clinical significance of defective dendritic cell differentiation in cancer[J].Clin Cancer Res,2000,6(5):1755-1766.
  • 7[5]de Smedt T,van Mechelen M,de Becker G,et al.Effect of interleukin-10 on dendritic cell maturation and function[J].Eur J Immunol,1997,27 (5):1229-1235.
  • 8[6]D′Orazio TJ,Niederkorn JY.A novel role for TGF-β and IL-10 in the induction of immune privilege[J].Nature,1998,160(5):2089-2098.
  • 9[7]Gabrilovich DI,Ishida T,Nadaf S,et al.Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function[J].Clin Cancer Res,1999,5(10):2963-2970.
  • 10[3]Steinman RM,Hawiger D,Liu K,et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance[J]. Ann NY Acad Sci, 2003,987:15.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部